Janssen has launched Rezolsta, a fixed-dose combination tablet containing the protease inhibitor darunavir and the pharmacoenhancer cobicistat, for the treatment of HIV infection.
Click to search or browse MIMS
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Access the full drug database and quick-reference tables on the go